Member access

4-Traders Homepage  >  Shares  >  Nyse  >  AbbVie Inc    ABBV   US00287Y1091

ABBVIE INC

 (ABBV)
7
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/15/2013 05/16/2013 05/17/2013 05/20/2013 05/21/2013 Date
46.03(c) 46.21(c) 47.17(c) 46.26(c) 46.54(c) Last
6 702 565 4 605 696 5 245 633 3 537 860 4 710 269 Volume
+1.50% +0.39% +2.08% -1.93% +0.61% Change
More quotes
Company
Formed in April 2012 when the Abbott Laboratories group’s pharmaceutical and biological product divisions split off, AbbVie specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn’s disease, thyroid disease,... 
Read more
More about the company
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 18 427 M
EBIT 2013 7 049 M
Net income 2013 4 455 M
Debt 2013 2 652 M
Yield 2013 3,44%
Sales 2014 18 873 M
EBIT 2014 7 261 M
Net income 2014 5 058 M
Debt 2014 2 200 M
Yield 2014 3,54%
PER 2013 16,45
PER 2014 14,28
EV / Sales 2013 4,14x
EV / Sales 2014 4,02x
Capitalization 73 707 M
More Financials
Latest news on ABBVIE INC
2d ago ABBVIE INC: AbbVie Initiates Phase 3 Study of Its Investigational Compound Atra..
5d ago ABBVIE INC: AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn..
7d ago ABBVIE INC: AbbVie to Present Data on Investigational Anti-Cancer Compounds at ..
05/14DJAbbVie, Alvine Pharma to Collaborate on Investigational Drug for Celiac Disea..
05/14 ABBVIE INC: AbbVie and Alvine to Collaborate on Investigational Oral Therapy fo..
05/14 ABBVIE INC: AbbVie and Alvine to Collaborate on Investigational Oral Therapy fo..
05/10DJAbbVie Chief Scientific Officer John Leonard to Retire
05/10DJPfizer Has Second Recall of Thyroid-Disorder Drug Levoxyl
05/07 ABBVIE INC: AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care..
05/06DJAbbVie's Investigational Hepatitis C Virus Regimen Gets Breakthrough-Therapy ..
05/06 ABBVIE INC: AbbVie's Investigational HCV Regimen Receives Breakthrough Therapy ..
04/30DJVertex Pharmaceuticals Swings to 1st-Quarter Loss on Write-Down
More news
Forum ABBVIE INC
Be the first to post a message on ABBVIE INC
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
AbbVie Inc : Income Statement Evolution
More Financials
EPS Revisions
AbbVie Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.